SISU operates medical-aesthetic clinics offering treatments such as anti-wrinkle injections, dermal and facial fillers, laser and teeth whitening. The company standardizes “facial feature” pricing for specific areas (lips, chin, under-eye, cheeks, brow) and plans instant online evaluations and digital booking. Founders describe a “face as a service” (FaaS) product and will launch an e-commerce platform in the U.S. The business currently has eight clinics in Ireland and plans 20 medical-retail clinics on the U.S. East Coast. SISU aims to apply a Warby Parker/One Medical playbook to the fragmented cosmetic-clinic market. The company raised institutional capital to fund U.S. expansion and platform development. The space they target — medical aesthetics — is projected to reach $14.5 billion by 2023, per the article.

Total raised

$6M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2020